Growth Metrics

BeOne Medicines (ONC) Income from Non-Controlling Interests (2017 - 2020)

Historic Income from Non-Controlling Interests for BeOne Medicines (ONC) over the last 4 years, with Q4 2020 value amounting to $96000.0.

  • BeOne Medicines' Income from Non-Controlling Interests fell 4216.87% to $96000.0 in Q4 2020 from the same period last year, while for Sep 2021 it was $96000.0, marking a year-over-year increase of 10270.65%. This contributed to the annual value of -$3.6 million for FY2020, which is 8548.72% down from last year.
  • BeOne Medicines' Income from Non-Controlling Interests amounted to $96000.0 in Q4 2020, which was down 4216.87% from -$1.4 million recorded in Q3 2020.
  • In the past 5 years, BeOne Medicines' Income from Non-Controlling Interests ranged from a high of $1.5 million in Q4 2018 and a low of -$1.4 million during Q3 2020
  • Over the past 4 years, BeOne Medicines' median Income from Non-Controlling Interests value was -$429000.0 (recorded in 2019), while the average stood at -$401666.7.
  • Within the past 5 years, the most significant YoY rise in BeOne Medicines' Income from Non-Controlling Interests was 349302.33% (2018), while the steepest drop was 51333.33% (2018).
  • Quarter analysis of 4 years shows BeOne Medicines' Income from Non-Controlling Interests stood at $43000.0 in 2017, then surged by 3493.02% to $1.5 million in 2018, then tumbled by 89.26% to $166000.0 in 2019, then crashed by 42.17% to $96000.0 in 2020.
  • Its Income from Non-Controlling Interests was $96000.0 in Q4 2020, compared to -$1.4 million in Q3 2020 and -$1.1 million in Q2 2020.